(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
批准号:
10594086
负责人:
Azra Bihorac
金额:
$27.89万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-03-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisBudgetsCessation of lifeClinicalClinical DataClinical Decision Support SystemsConsensusCoupledDataData ElementData SetDatabasesDecision Support SystemsDependenceDevelopmentDialysis procedureEarly identificationFloridaGoalsHealthHospital CostsHospitalsInterventionKnowledgeLaboratoriesMedical HistoryMedical centerMethodsMissionModelingPatient CarePatient-Focused OutcomesPatientsPerformancePersonsPharmaceutical PreparationsPharmacistsPhenotypePhysiciansPredictive AnalyticsPreparationProcessReadinessResearchRiskStandardizationTestingTextTimeUnited States National Institutes of HealthUniversitiesValidationcost effectivenessdata integrationdeep learningdemographicseffectiveness evaluationexperiencehealth care availabilityhealth datahigh riskimprovedimproved outcomemodel developmentmultimodalitynephrotoxicityparent projectrisk prediction modelsocial health determinantssocial integrationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Acute Kidney Injury (AKI) in the US has increased by 38% over the last eight years, with drugs as a major
contributor to AKI in hospitalized patients. Drug-associated AKI (D-AKI) results in severe consequences with
approximately 40% of patients experiencing in-hospital death or dialysis dependence. We have determined
that many patients often continue to receive nephrotoxic drugs until AKI becomes severe. The goal of the
parent project is to assess the effectiveness of a clinical decision support system (CDSS) augmented with
real-time predictive analytics to support a pharmacist-led intervention to reduce the progression and
complications of D-AKI. Specifically, we aim to 1) optimize the clinical performance of risk-alerts generated by
a CDSS; 2) test whether an advanced CDSS coupled with a pharmacist-led intervention improves outcomes
for patients with D-AKI; and 3) determine physician acceptance and cost-effectiveness of our intervention. This
requires harmonization and cross validation of electronic AKI phenotypes and interpretable deep learning AKI
transition model using data from two different EMR platforms, EPIC used by the University of Florida Health
(UFH) and Cerner used by the University of Pittsburgh Medical Center (UPMC). While data integration,
harmonization, and standardization processes are being developed for demographics and medical history,
medications, laboratory results, and vital signs, it is lacking AI/ML ready datasets with social determinants of
health (SDOH) exposome data and clinical notes that may carry important information about patient heath
status and access to health care that may improve performance of the models. The proposed supplement
project will develop integration, standardization, and processing tools and pipeline to create multimodal AI/ML
ready datasets with SDOH and text data with aims: Aim 1: Preparation of AI/ML ready SDOH data. We will
develop and assess tools for a) extracting, cleaning, imputing, preprocessing and representing data for various
exposures contributing to a person’s SDOH exposome, b) integration of SDOH data to databases of University
of Florida (UF) and University of Pittsburgh (UPitt) for them to be used in D-AKI risk model development and
validation. Aim 2: Preparation of multimodal AI/ML ready data that includes unstructured text data. We
will develop and assess tools for a) extracting, cleaning, preprocessing and representing unstructured text data
b) integration of clinical data and unstructured text data to prepare multimodal AI/ML ready datasets at UF. The
proposed supplement project will extend the aims of the parent project by including development of (1) a tool
for integration of SDOH (2) a tool for extraction and integration of unstructured text data (3) tools for cleaning,
imputing, preprocessing data and generalizable methods for improving the AI/ML-readiness of datasets
through consensus-driven AI datasheets. The completion of these aims will provide multimodal AI/ML ready
data with additional data elements, that require effort and budget not covered by parent project, to
improve efficiency and performance of the D-AKI risk prediction models and other AI applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10858694
-
项目类别:
-
资助金额:$637.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10472824
-
项目类别:
-
资助金额:$588.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10414976
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10396041
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10609525
-
项目类别:
-
资助金额:$63.56万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10178157
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10209005
-
项目类别:
-
资助金额:$56.22万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10154047
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10580785
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10374834
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10602426
-
项目类别:
-
资助金额:$55.72万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10445486
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Integrating data, algorithms and clinical reasoning for surgical risk assessment
-
批准号:9233163
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10681418
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8280337
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8076251
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8496075
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:7787562
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
海外基金